
Overview
Paul Masci is a Hematologist Oncology provider in Wooster, Ohio. Dr. Masci has been practicing medicine for over 35 years and is rated as an Experienced provider by MediFind in the treatment of Wilms Tumor. His top areas of expertise are Multiple Myeloma, Small Cell Lung Cancer (SCLC), Childhood Iron Deficiency Anemia, and Lung Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- HMO
- EPO
- HMO
- PPO
- MEDICARE SNP
- MEDICARE MAPD
- OTHER MEDICARE
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- INDEMNITY
- PPO
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE PART D
- MEDICARE SNP
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
721 East Milltown Road, Wooster, OH 44691
Esther Rehmus is a Hematologist Oncology provider in Akron, Ohio. Dr. Rehmus is rated as a Distinguished provider by MediFind in the treatment of Wilms Tumor. Her top areas of expertise are Paget Disease of the Breast, Inflammatory Breast Cancer, Non-Hodgkin Lymphoma, Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration.
Cleveland Clinic Main Campus
Chistopher Wee is a Hematologist Oncology specialist and a Hematologist in Cleveland, Ohio. Dr. Wee is rated as a Distinguished provider by MediFind in the treatment of Wilms Tumor. His top areas of expertise are Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, and Gamma Knife Radiosurgery.
University Hospitals Medical Group Inc
Pedro Barata is a Hematologist Oncology specialist and a Hematologist in Cleveland, Ohio. Dr. Barata has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Wilms Tumor. His top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, WT1-Related Wilms Tumor Syndromes, and Nephrectomy. Dr. Barata is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Multiple MyelomaDr. Masci isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Acute Mountain SicknessDr. Masci isAdvanced. Learn about Acute Mountain Sickness.
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Masci isAdvanced. Learn about Anemia.
- Breast CancerDr. Masci isAdvanced. Learn about Breast Cancer.
- Carcinoid SyndromeDr. Masci isAdvanced. Learn about Carcinoid Syndrome.
- Childhood Acute Myeloid Leukemia
- Experienced
- Acute Hepatic Porphyria (AHP)Dr. Masci isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Lymphoblastic Leukemia (ALL)Dr. Masci isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Masci isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaDr. Masci isExperienced. Learn about Acute Promyelocytic Leukemia.

